TAKENOSHITA Seiichi

写真a

Title

President

Mail Address

E-mail address

Current Affiliation Organization 【 display / non-display

  • Duty ,  Fukushima Medical University ,  President ,  President

Field of expertise (Grants-in-aid for Scientific Research classification) 【 display / non-display

  • Gastroenterological Surgery

  • Surgery in General

  • Molecular Biology

 

Research Career 【 display / non-display

  • Mutation Analysis at the Entire Coding Region of the Transformation Growth Factor Beta Receptor Gene and Smad Related Gene in cancer.

  • Efficacy of the Combined Therapy of Stable Strontium (Sr) with Multidisciplinary Treatment for Advanced Cancer

  • Aualysis of Genomic Structure and Search for Mutation of Tumor-associated Gene

Papers 【 display / non-display

  • The Genomic Structure of the Gene Encoding the Human Transforming Growth Factor β Type Ⅱ Receptor (TGF-β RⅡ)

    Genomics ,  36   341 - 344 ,  1996

    Single Author

  • Selective Elevation of the N'-Acetylspermidine Level in Human Colorectal Adenocarcinomas

    Cancer Research ,  44   845 - 847 ,  1984

    Single Author

  • Temporal Changes in Neuro-Immuro Endocrine System with Adjuvant Radiotherapy for Advanced Rectal Cancer

    Anticancer Research ,  14   1257 - 1264 ,  1994

    Single Author

  • Inhibitory Effects of Combined Administration of 5-FV and Krestin on Liver Cancer KDH-8 in WKA/H pats

    Journal of Iuvestigative Surgery ,  8   1 - 5 ,  1995

    Single Author

  • Immunoscintigraphy Using 99mTC-Labeled Anti-CEA Monocloval Antibody for Patients with Colorectal Cancer.

    Anticancer Research ,  15   471 - 476 ,  1995

    Single Author

display all >>

Books 【 display / non-display

  • Levels of Free and Acetylated Polyamines in Human Colorectal Tumors

    (Page:8/,375-382)

    Polymines : Basic and Clinical Aspects VNU Scieuce Press ,  1985

Presentations 【 display / non-display

  • [14C]-L-FAMTを用いた腫瘍細胞型アミノ酸トランスポーターLAT1の活性測定法の開発

    第54回日本核医学会学術総会 , 

    2014.11
     
     

  • 骨髄由来抑制細胞(MDSC)の血清濃度は消化管癌患者の予後の指標として有効である

    日本癌治療学会 , 

    2014.06
     
     

  • 全身18F-FDG PET/MRIおよびPET/CTに由来する正常組織の標準化取り込み量の比較

    日本放射線技術学会総会学術大会 , 

    2014.02